Publikationen in Zusammenarbeit mit Forschern von Stanford University School of Medicine (9)

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  2. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248

  3. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656

2018

  1. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study

    Rheumatology (United Kingdom), Vol. 57, Núm. 2, pp. 370-381

  2. There is a need for new systemic sclerosis subset criteria. A content analytic approach

    Scandinavian Journal of Rheumatology, Vol. 47, Núm. 1, pp. 62-70

2017

  1. Overexpression of the cytokine BAFF and autoimmunity risk

    New England Journal of Medicine, Vol. 376, Núm. 17, pp. 1615-1626

2014

  1. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria

    Journal of Clinical Epidemiology, Vol. 67, Núm. 6, pp. 706-714

2013

  1. 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1747-1755

  2. 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Arthritis and Rheumatism, Vol. 65, Núm. 11, pp. 2737-2747